Expert Ratings for Boston Scientific
Portfolio Pulse from Benzinga Insights
Analysts have provided bullish ratings for Boston Scientific (NYSE:BSX) in the last quarter, with 5 bullish, 4 somewhat bullish, and 1 indifferent. The average 12-month price target for the company is $60.6, an increase of 3.71% from the previous average of $58.43.
July 28, 2023 | 1:00 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Boston Scientific received mostly bullish ratings from analysts, which could positively impact its stock price.
Analysts' ratings are a significant factor that investors consider when making investment decisions. The bullish ratings and increased price target for Boston Scientific indicate a positive outlook for the company, which could lead to an increase in its stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100